DeepMed Research

WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium

Phase 2

Completed

Conditions: Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter

First Posted Date: 2006-04-03

Last Posted Date: 2018-08-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 71

Registration Number: NCT00310011

Locations: 🇺🇸
Carolinas Hematology-Oncology Associates, Charlotte, North Carolina, United States
🇺🇸
Regional Cancer Center, Greensboro, North Carolina, United States
🇺🇸
Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations

Phase 4

Terminated

Conditions: Snake Envenomation

Interventions: Biological: Crotaline Polyvalent Immune Fab (ovine) (active initial and maintenance therapy)
Biological: Crotaline Immune Fab (ovine) (active initial therapy; placebo maintenance therapy)
Biological: Placebo

First Posted Date: 2006-03-16

Last Posted Date: 2023-12-01

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 13

Registration Number: NCT00303303

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
Richland Memorial Hospital, Columbia, South Carolina, United States
🇺🇸
Carolinas Medical Center, Charlotte, North Carolina, United States

and more 1 locations

Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy

Not Applicable

Withdrawn

Conditions: Neutropenia
Unspecified Adult Solid Tumor, Protocol Specific
Infection
Unspecified Childhood Solid Tumor, Protocol Specific

Interventions: Drug: daptomycin
Drug: vancomycin

First Posted Date: 2006-02-24

Last Posted Date: 2018-08-10

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT00296049

Locations: 🇺🇸
Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Phase 1

Completed

Conditions: Leukemia

First Posted Date: 2006-02-24

Last Posted Date: 2018-08-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 53

Registration Number: NCT00295841

Locations: 🇺🇸
Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

First Posted Date: 2006-01-18

Last Posted Date: 2017-01-19

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 49

Registration Number: NCT00278460

Policosanol for the Treatment of Hypercholesterolemia

Not Applicable

Completed

Conditions: Hyperlipidemia

First Posted Date: 2005-11-18

Last Posted Date: 2023-03-30

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 40

Registration Number: NCT00255216

Locations: 🇺🇸
Center for Cardiovascular Health, Charlotte, North Carolina, United States

Improving Sleep and Psychological Functioning in People With Depression and Insomnia

Phase 4

Completed

Conditions: Sleep Initiation and Maintenance Disorders
Depression

Interventions: Drug: Eszopiclone
Drug: Placebo
Drug: Fluoxetine

First Posted Date: 2005-11-02

Last Posted Date: 2018-08-28

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT00247624

Locations: 🇺🇸
Wake Forest University Health Sciences; Department of Psychiatry and Behavioral Medicine, Winston-Salem, North Carolina, United States

Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese

Not Applicable

Completed

Conditions: Heart Diseases
Metabolic Syndrome X
Cardiovascular Diseases
Obesity

Interventions: Behavioral: Exercise
Behavioral: Health Education Control
Behavioral: Weight Loss

First Posted Date: 2005-07-14

Last Posted Date: 2018-08-15

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 288

Registration Number: NCT00119795

Locations: 🇺🇸
Davidson County Coopertive Extension, Lexington, North Carolina, United States
🇺🇸
Forsyth County Cooperative Extension Center, Winston-Salem, North Carolina, United States
🇺🇸
Guilford County, North Carolina Cooperative Extension Center, Greensboro, North Carolina, United States

St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer
Hot Flashes

Interventions: Drug: St. John's Wort

First Posted Date: 2005-05-04

Last Posted Date: 2021-09-29

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 9

Registration Number: NCT00110136

Locations: 🇺🇸
Feist-Weiller Cancer Center at Louisiana State University Health Sciences, Shreveport, Louisiana, United States
🇺🇸
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸
Cancer Research for the Ozarks, Springfield, Missouri, United States

and more 16 locations

Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes

Phase 2

Terminated

Conditions: Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

First Posted Date: 2005-03-04

Last Posted Date: 2018-08-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 5

Registration Number: NCT00104806

Locations: 🇺🇸
Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy